DJIA 17,678.70 6.10 0.03%
NASDAQ 4,771.76 13.88 0.29%
S&P 500 2,057.09 5.27 0.26%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

159.73 -0.08 (-0.05%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMGN $159.73 -0.05%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $159.62
Previous Close $159.81
Daily Range $157.67 - $161.48
52-Week Range $108.20 - $173.14
Market Cap $121.5B
P/E Ratio 25.17
Dividend (Yield) $3.16 (2.0%)
Ex-Dividend Date
Dividend Pay Date
02/10/15
03/06/15
Volume 3,149,142
Average Daily Volume 3,621,992
Current FY EPS $8.59

Sector

Healthcare

Industry

Drugs

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary Rss Feed

These 3 Pharmaceutical Companies Control Roughly Half of All Cancer Drug Sales

Global cancer drug sales totaled $91 billion in 2013 and are expected to breach $100 billion in sales sooner than you think. Yet, three big pharmaceutical companies currently control about half of all cancer drug sales.

TrovaGene Partners with Leading Cancer Research Institutes - Analyst Blog

5 Big Biotech Earnings Releases To Watch This Week

IYH, AMGN, ABBV, CELG: Large Inflows Detected at ETF

These 3 Dividend Stocks Could Crush the Market in 2015

AbbVie, Amgen, and Pfizer are three dividend stocks that could crush the broader market this year. Here's why.

Will Amgen (AMGN) Keep the Earnings Streak Alive in 4Q? - Analyst Blog

Medivation and Astellas Report TERRAIN Data on Xtandi - Analyst Blog

Will Millennials Drive In 2-0-1-5?

What Lessons Has Express Scripts Taught Us? The Future For The Pharmaceutical Industry

Curis Up on Immuno-Oncology Agreement with Aurigene - Analyst Blog

See More AMGN News...

AMGN's Top Competitors

AMGN $159.73 (-0.05%)
Current stock: AMGN
GILD $107.12 (1.50%)
Current stock: GILD
CELG $124.12 (0.19%)
Current stock: CELG
$0.00 (0.00%)
Current stock: